TLIS - Talis Biomedical Corp
IEX Last Trade
4.41
4.410 100.000%
Share volume: 0
Last Updated: Fri 30 Aug 2024 08:00:00 PM CEST
Surgical and Medical Instrument Manufacturing :
1.09%
PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
Fundamental analysis
13%
Profitability
0%
Dept financing
11%
Liquidity
75%
Performance
10%
Performance
5 Days
0 0%
1 Month
0 0%
3 Months
-15.69%
6 Months
-79.33%
1 Year
-77.55%
2 Year
-75.34%
Key data
Stock price
$4.41
DAY RANGE
N/A - N/A
52 WEEK RANGE
$1.60 - $9.60
52 WEEK CHANGE
-$77.40
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/12/2024
Company detail
CEO: Robert J. Kelley
Region: US
Website: talisbio.com
Employees: 260
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing
Region: US
Website: talisbio.com
Employees: 260
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing
Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also offers Talis 1 COVID-19 Test System, which focuses on detection of SARS-CoV-2, the virus that causes COVI-19.
Recent news